Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA's Gottlieb Pushing 'Seamless' Clinical Trials For Faster Development

Executive Summary

US FDA Commissioner notes that combined-phase clinical trials could be expanded beyond oncology as one way of reducing drug development costs.


Related Content

Hypertension Drug Development To Be Streamlined Under US FDA Guidance
From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program
FDA Bests Annual Novel Drug Approval Record With Four Oks In One Week
Gene Therapy Guidances Will Focus On Specific Diseases, Gottlieb Says
Payers Could Guarantee Biosimilar Market Share, FDA's Gottlieb Suggests
US FDA To Publish Own Datasets In Latest Signal Of Enhanced Transparency
Alzheimer's Guidance Coming From US FDA, Part Of Broader OND Reform
Latest R&D Spending Benchmark Study Puts Cancer Drug Costs At $648M
Gene Therapy Platforms May Require Less Preclinical Data, Gottlieb Says





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts